Real-World Evidence on Hospitalization Costs of Pediatric Neoplasm Patients in China: Patterns, Trends, and Associated Factors From a Retrospective Cohort Study - PubMed
5 hours ago
- #pediatric neoplasms
- #hospitalization costs
- #China healthcare
- Study analyzes hospitalization costs for pediatric neoplasm patients in China from 2017-2023.
- Pediatric neoplasm patients (1.91% of 688,131 hospitalizations) had higher costs than non-neoplasm patients, with malignant neoplasms being the most expensive.
- Total costs for neoplasm patients declined by 26.88%, driven by a 52.87% reduction in drug costs.
- Leukemia was the most prevalent condition, while rare high-cost entities like secondary malignant neoplasms were among the most expensive.
- Key cost drivers included sex, insurance type, pathology, surgical interventions, length of stay, and hospital characteristics.
- Highlights the need for better insurance coverage, early diagnosis, and equitable resource allocation to reduce disparities.